INTERTAN™
-
Recon
Smith+Nephew introduces ground-breaking assurance program for TRIGEN™ INTERTAN™ Intertrochanteric Hip Fracture Nail
LONDON, Sept. 26, 2019 /PRNewswire/ — Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announced the launch of its new INTERTAN Product…
Read More » -
Recon
Two new studies demonstrate INTERTAN™ Intertrochanteric Antegrade Nail improves patient outcomes and lowers healthcare costs when treating hip fractures
LONDON, Oct. 17, 2018 /PRNewswire/ — Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today announced at the Orthopaedic Trauma Association…
Read More »